Irbesartan and Hydrochlorothiazide
These highlights do not include all the information needed to use IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLETS.IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997
83f4acc1-697a-4770-b554-1b9a8fb5de74
HUMAN PRESCRIPTION DRUG LABEL
Oct 20, 2021
Teva Pharmaceuticals USA, Inc.
DUNS: 001627975
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Irbesartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Irbesartan and Hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information